Trials / Completed
CompletedNCT03351322
ENERGI-F701 for Female Hair Loss Treatment
A Randomized, Double-Blind, Active-controlled, Parallel, Phase II Study to Evaluate Efficacy and Safety of ENERGI-F701 Solution in Female Subjects With Hair Loss
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 67 (actual)
- Sponsor
- Energenesis Biomedical Co., Ltd. · Industry
- Sex
- Female
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the efficacy and safety of ENERGI-F701 Solution in female subjects with hair loss.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ENERGI-F701 | ENERGI-F701 are applied for treatment of hair loss. |
| DRUG | Regaine | Regaine are applied for treatment of hair loss. |
Timeline
- Start date
- 2018-05-23
- Primary completion
- 2019-11-29
- Completion
- 2019-12-26
- First posted
- 2017-11-22
- Last updated
- 2020-11-24
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT03351322. Inclusion in this directory is not an endorsement.